Skip to main content
Figure 3 | BMC Gastroenterology

Figure 3

From: Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study

Figure 3

ROC curve for validity of pretreatment ALT for severe vs. minimal inflammation. Part ‘a’ shows AUROC of pre-treatment ALT for severe compared to minimal liver inflammation in males, having a value of 0.871. Part ‘b’ shows AUROC of pre-treatment ALT for severe compared to minimal liver inflammation in females, a value of 0.744. Pre-treatment ALT is moderately accurate in measuring severe as compared to minimal liver inflammation in both genders, more in males as compared to the females.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us